Literature DB >> 35129631

The association between laryngopharyngeal reflux and insomnia.

Jeong Wook Kang1, Jung Min Park1, Young Chan Lee1, Young-Gyu Eun2.   

Abstract

OBJECTIVES: To evaluate the prevalence of insomnia in patients with laryngopharyngeal reflux (LPR) and to analyze the relationship between the severity of insomnia and LPR-related symptoms.
METHODS: We analyzed 69 patients with LPR and 61 healthy controls. The LPR was confirmed via the 24-h hypopharyngeal-esophageal multichannel intraluminal impedance pH monitoring. Reflux symptoms and sleep disturbances were assessed using the Reflux Symptom Index and Insomnia Severity Index. We compared the prevalence of insomnia between the two groups. We analyzed the relationship between reflux symptoms and severity of insomnia.
RESULTS: The prevalence of insomnia was significantly higher in patients with LPR than in healthy controls (46.3% vs. 29.5%; p = 0.049). The severity of reflux-related symptoms was correlated with insomnia severity (rho = 0.44; p < 0.001). Patients with LPR with nighttime reflux were more likely to have sleep disturbances than patients with LPR without nighttime reflux.
CONCLUSION: Patients with LPR are more likely to experience insomnia than healthy controls, and the severity of reflux symptoms was related to the severity of insomnia.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Impedance monitoring; Insomnia; Laryngopharyngeal reflux; Pharyngeal reflux; pH monitoring

Mesh:

Year:  2022        PMID: 35129631     DOI: 10.1007/s00405-022-07280-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  36 in total

Review 1.  Quality of life measurement in gastroenterology: what is available?

Authors:  R F Yacavone; G R Locke; D T Provenzale; G M Eisen
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders.

Authors:  J A Koufman; M R Amin; M Panetti
Journal:  Otolaryngol Head Neck Surg       Date:  2000-10       Impact factor: 3.497

Review 3.  Gastroesophageal reflux disease and sleep disturbances.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa; Ronnie Fass
Journal:  J Gastroenterol       Date:  2012-05-17       Impact factor: 7.527

Review 4.  [Laryngopharyngeal reflux and chronic rhinosinusitis].

Authors:  J Wang; Y Zhao; J J Ren; L Lei; Y Xu
Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2016-10-20

Review 5.  Otolaryngologic manifestations of gastro-oesophageal reflux disease.

Authors:  E C Klinkenberg-Knol
Journal:  Scand J Gastroenterol Suppl       Date:  1998

6.  Morbidity associated with sleep disorders in primary care: a longitudinal cohort study.

Authors:  Mari-Ann Wallander; Saga Johansson; Ana Ruigómez; Luis A García Rodríguez; Roger Jones
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 7.  Gastroesophageal reflux disease and sleep.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa; Ronnie Fass
Journal:  Gastroenterol Clin North Am       Date:  2013-03       Impact factor: 3.806

8.  Effects of gastroesophageal reflux disease on sleep and outcomes.

Authors:  Reema Mody; Susan C Bolge; Hema Kannan; Ronnie Fass
Journal:  Clin Gastroenterol Hepatol       Date:  2009-04-16       Impact factor: 11.382

Review 9.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

Review 10.  The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life.

Authors:  William R Lenderking; Eric Hillson; Joseph A Crawley; David Moore; Richard Berzon; Chris L Pashos
Journal:  Value Health       Date:  2003 Sep-Oct       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.